Detecting Prion Oligomers with New Antibodies
Author Information
Author(s): Tayebi Mourad, Jones Daryl Rhys, Taylor William Alexander, Stileman Benjamin Frederick, Chapman Charlotte, Zhao Deming, David Monique
Primary Institution: Royal Veterinary College
Hypothesis
The development of antibodies that can specifically recognize oligomeric forms of PrPSc is crucial for early diagnosis of prion diseases.
Conclusion
The study demonstrates that newly developed anti-PrP monoclonal antibodies can effectively detect PrPSc oligomers, which may aid in diagnosing prion diseases at an early stage.
Supporting Evidence
- PRIOC mAbs were able to bind soluble oligomers formed of Aβ and α-synuclein.
- PRIOC mAbs did not bind to monomeric recombinant and cellular prion proteins.
- The antibodies showed strong immunoreactivity in prion-permissive neuroblastoma cell lines.
Takeaway
Scientists created special antibodies that can find tiny pieces of a harmful protein linked to brain diseases, helping doctors catch these diseases early.
Methodology
Monoclonal antibodies were produced by immunizing Prn-p0/0 mice with native PrP-coated microbeads and were characterized using ELISA, Western blotting, and immunofluorescence.
Limitations
The study primarily focuses on mouse models and may not fully translate to human prion diseases.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website